Brandes Investment Partners 13F: Adds $18M to CI Stake

Brandes Investment Partners added 64,607 shares of The Cigna Group (NYSE: CI) to its portfolio, according to its latest Form 13F filing with the Securities and Exchange Commission for the period ending May 15, 2026. This addition grew the firm's position in the health insurance giant by 6.842%.

Brandes Investment Partners Expands Its Cigna Stake

The investment manager brought its total holding to 1,008,869 shares of the healthcare provider. That is up from its previous position of 944,262 shares. Based on Cigna's stock price at the end of the reporting period, this block of shares was valued at $278,124,998.53.

Because Form 13F filings are backward-looking documents, they show a firm's stock holdings as of a specific past date. This means the report is a snapshot from May 15, 2026, and may not represent where Brandes Investment Partners holds its money today. Still, the decision to bolster its stake shows a clear interest in the health insurer during the first half of the year. This contrasts with some of the firm's other recent moves, where it trimmed holdings in technology and manufacturing names like Flex Ltd. and Graham Corporation.

Cigna Stock Trades Near Key Moving Averages

On Saturday, Cigna shares closed at a spot price of $275.68. The stock has been trading slightly below its 50-day moving average of $282.56 and its longer-term 200-day moving average of $279.85. Moving averages are technical tools that smooth out price data to help investors spot overall trends.

Cigna's share price has fluctuated between a 52-week low of $239.51 and a 52-week high of $315.47. The stock currently has a price-to-earnings ratio of 11.355813, which compares a company's share price to its earnings to show if it is priced reasonably. Its forward P/E ratio, which uses projected future earnings instead, stands at 8.20501.

Revenue and Profitability Trends at Cigna

The healthcare giant has maintained a large top-line presence, generating $282,382,008,320.00 in revenue. That represents a revenue growth rate of 6.7%. Cigna reported earnings per share of $24.17, with a return on equity of 16.758% and a net margin of 2.272%. Investors tracking the company's financial schedule can look forward to November 5, 2026, when Cigna is next scheduled to release its quarterly earnings results.

Dividend Yield and Payouts

Cigna also offers regular payouts to its shareholders. The company has an annual dividend rate of $6.24 per share, which provides investors with a dividend yield of 2.27%. The payout ratio stands at 25.39%, meaning Cigna distributes about a quarter of its earnings back to its stockholders while keeping the rest to fund its operations and future growth.

Wall Street Analysts Adjust Cigna Price Targets

Several major investment banks and research firms have updated their outlooks on Cigna recently. On October 2, 2026, Piper Sandler maintained an Overweight rating on the stock and adjusted its price target to $370.0. A day earlier, on October 1, 2026, RBC Capital reiterated its Outperform rating with a price target of $337.0.

Some analysts have taken a more cautious stance. Jefferies downgraded the stock to a Hold rating on August 4, 2026, setting a target price of $307.0. Raymond James also downgraded Cigna on August 3, 2026, shifting to an Outperform rating with a target of $320.0. Other firms keeping tabs on the stock include Wells Fargo, which maintained an Equal-Weight rating with a $307.0 target on July 31, 2026, and Guggenheim, which kept a Buy rating with a $361.0 target on the same day. Barclays held its Equal-Weight rating with a $310.0 target on July 31, 2026, while Bernstein maintained an Outperform rating with a $381.0 target on July 9, 2026.

Across 25 analyst opinions, the stock has a consensus buy recommendation. The average price target among these analysts is $339.36, with a high estimate of $400.0 and a low estimate of $290.0.

What The Cigna Group Does

The Cigna Group is a major healthcare services company. It operates through two main segments: Evernorth Health Services and Cigna Healthcare. Evernorth manages pharmacy benefits, home delivery pharmacy services, and care coordination. The Cigna Healthcare segment provides health insurance plans directly to employers, individuals, and government programs.

Looking Ahead at Brandes' Strategy

This transaction highlights how Brandes Investment Partners is positioning its capital. While the fund has been scaling back its holdings in smaller industrial and technology companies, it chose to build on its massive investment in Cigna. Stock market observers will have to wait for the firm's next round of disclosures to see if this healthcare-focused trend continues.